Plastic packaging specialist China Bottles (CB) says that nearly two thirds of the $3.3m worth of contracts it signed in June were with pharmaceutical companies based outside its home territory.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
in-PharmaTechnologist.com's periodic round-up of developments in
the field of pharmaceutical facilities includes news of two
environmental fines, MHRA plant approval and a strike at Teva.
UK-based Sinclair Pharmaceuticals has entered into a manufacturing
and distribution agreement with Wockhardt, an Indian pharmaceutical
and biotech company.
Outsourcing-Pharma.com presents its latest round-up of news in the
contract development and manufacturing sector, with updates from
Rentschler Biotechnologie, Eden Biodesign, Emcure Pharmaceuticals
and new start-up Appian Labs.
Visiongain's third annual conference on Pharmaceutical
Anti-counterfeiting Strategies kicks off next week, covering many
aspects of the problem from technological deterrents, regulatory
developments in the EU and US and the implications...
European pharmaceutical manufacturers stepped up calls for a
blanket ban on repackaging of pharmaceuticals last week, suggesting
that this would be the single most effective way to seal the supply
chain for counterfeiting drugs.
Patheon gave an update on its restructuring plans in Puerto Rico
yesterday, saying that its plant in Manati will be updated to
provide contract manufacturing of high-potency drugs and controlled
substances.
Introgen Therapeutics says advances in its biologics manufacturing
and storage technologies have allowed it to broaden the scope of
its contract manufacturing operations and set up a new unit called
Introgen Technical Services (ITS).
West Analytical Services says it has introduced a testing platform
to help customers testing pulmonary and nasal drug products and
their delivery devices.
Pharmaceutical manufacturers are now withdrawing from manufacturing
at an unprecedented rate, with four of the top 10 players
announcing major new outsourcing programmes in 2007, says IMS in a
new document which explores the implications...
Catalent Pharma Solutions has reported a profit drop in its latest
financial results, completed the sale of one of its businesses, and
is undergoing regulatory scrutiny over the overall control and
management of quality systems at...
Germany's Rentschler Biotechnologie and Boehringer Ingelheim have
inked a preferred partnership agreement to jointly offer customers
a more streamlined biopharmaceutical production option.
Bushu Pharmaceuticals, Japan's largest dedicated contract
manufacturer, has been going from strength to strength as Japan's
pharma outsourcing industry awakens.
2005 marked the real beginning of contract manufacturing in Japan,
which had been held back by an overly-cautious regulatory
environment and significant and unique quality and specification
demands in the marketplace.
The contract manufacturing organisation (CMO) business model needs
to change if companies expect to remain competitive in this
evolving industry, which is tipped to see tough times ahead.
Overall, 2007 was another stellar year for contract service
providers, particularly those at the early-stage end of
development, although companies are advised to watch out for a
tougher environment ahead.
Stiefel Laboratories, Biopharm Services, Multisorb Technologies,
the Pharmaceutical Research and Manufacturers of America, Catalent
Pharma Solutions and Chromatide have all had people on the
move in the world of pharmaceutical manufacturing.
India's Jubilant Organosys has made good on promises to make
acquisitions in the contract research and manufacturing services
(CRAMS) sector with a $255m deal to buy Draxis Health of Canada.
Three of India´s large pharmaceutical manufacturers, Dr Reddy's,
Ranbaxy Laboratories and Shilpa Medicare have just announced new
merger and acquisition (M&A) deals.
Steven Liberty, senior vice president of operations for Patheon's
North American businesses spoke at Interphex on the strategies
contract manufacturing organisations (CMOs) can use to obtain a
competitive advantage.
Sterile process engineering consultancy firm Isogen is taking a
maiden voyage into the manufacturing side of drugs with the
construction of its first facility, aimed to fill a gap in
small-scale injectables.
The pharmaceutical industry has lost confidence in the UK as a
place to do business to an "alarming degree" and the
situation is only set to deteriorate, reveals new research.
The generic pharmaceutical industry has given short shrift to the
latest congressional attempt to construct a viable approval pathway
for biosimilars in the US.
A new, more patient-friendly presentation of the growth hormone
treatment Omnitrope (rDNA somatropin) has been launched in the US
by Sandoz, the generics division of Swiss-based Novartis.
Bosch Packaging Technology will be rolling out a range of new and
recently launched processing and packaging solutions at the
Interpack 2008 exhibition in Düsseldorf, Germany this April,
including a new line for high-potency compounds.
Jubilant Organosys, India's largest custom research and
manufacturing services (CRAMS) provider, has scored new contracts
to the tune of $92m for the year thus far as its business continues
to gather momentum.
Four of India's biggest vaccine manufacturers have had their
licenses suspended by the Indian government after failing to meet
good manufacturing practise (GMP) requirements, according to local
media reports.
Germany put in a strong showing as category winners were announced
for the fourth annual Facility of the Year Awards (FOYA)
recognising innovation in pharmaceutical manufacturing projects.
Another sharp decline in biomedical production saw overall
manufacturing output in Singapore fall for the second month running
in December, prompting fears that the heavily trade-reliant economy
could buckle under a looming US recession.
